Ruxolitinib sulfate

Overview

Ruxolitinib sulfate (INCB018424 sulfate) is the first potent, selective JAK1/2 inhibitor to enter the clinic with IC 50 s of 3.3 nM/2.8 nM, and has > 130-fold selectivity for JAK1/2 versus JAK3 .

Application

Products | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Autophagy | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > JAK | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-50859
• CAS No.: 1092939-16-6
• Molecular Formula: C17H20N6O4S
• Molecular Weight: 404.44
• Purity: 99.98%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Source

Original product source